Prognostic Role of MR Imaging in Nonischemic Myocardial Disease

Magnetic Resonance Imaging Clinics of North America

Volumn 23, Issue 1, 2015, Pages 89-94

  Kallianos, Kimberly ^a   Moraes, Gustavo L ^b   Ordovas, Karen G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL MÃE DE DEUS   (Brazil)

Author keywords

Amyloidosis; Cardiac magnetic resonance; Cardiomyopathy; Delayed enhancement; Myocarditis; Prognosis; Sarcoidosis

Indexed keywords

AMYLOIDOSIS; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL INDICATOR; CLINICAL PRACTICE; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; EARLY INTERVENTION; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MYOCARDIAL DISEASE; MYOCARDITIS; NONISCHEMIC MYOCARDIAL DISEASE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SARCOIDOSIS; TREATMENT RESPONSE; COMPUTER ASSISTED DIAGNOSIS; EVIDENCE BASED MEDICINE; HEART DISEASES; IMAGE ENHANCEMENT; MYOCARDIAL ISCHEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

EVIDENCE-BASED MEDICINE; HEART DISEASES; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84919429592     PISSN: 10649689     EISSN: 15579786     Source Type: Journal    
DOI: 10.1016/j.mric.2014.09.004     Document Type: Review

References (20)

1. Kindermann I., Kindermann M., Kandolf R., et al. Predictors of outcome in patients with suspected myocarditis. Circulation 2008, 118:639-648.
2. Grun S., Schumm J., Greulich S., et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. JAm Coll Cardiol 2012, 59(18):1604-1615.
3. De Cobelli F., Pieroni M., Esposito A., et al. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. JAm Coll Cardiol 2006, 47(8):1649-1654.
4. Curtis J.P., Sokol S.I., Wang Y., et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. JAm Coll Cardiol 2003, 42(4):736-742.
5. Gulati A., Jabbour A., Ismail T.F., et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013, 309(9):896-908.
6. Assomull R.G., Prasad S.K., Lyne J., et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. JAm Coll Cardiol 2006, 48(10):1977-1985.
7. Taylor A.J., Elsik M., Broughton A., et al. Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy. Europace 2010, 12(5):708-713.
8. Olivotto I., Maron M.S., Autore C., et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. JAm Coll Cardiol 2008, 52(7):559-566.
9. Gersh B.J., Maron B.J., Bonow R.O., et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. JAm Coll Cardiol 2011, 58(25):2703-2738.
10. O'Mahony C., Tome-Esteban M., Lambiase P.D., et al. Avalidation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy. Heart 2013, 99(8):534-541.
11. Adabag A.S., Maron B.J., Applebaum E., et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. JAm Coll Cardiol 2008, 51(14):1369-1374.
12. Bruder O., Wagner A., Jensen C.J., et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. JAm Coll Cardiol 2010, 56(11):875-887.
13. Green J.J., Berger J.S., Kramer C.M., et al. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 2012, 5(4):370-377.
14. Moon J.C., Reed E., Sheppard M.N., et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. JAm Coll Cardiol 2004, 43(12):2260-2264.
15. Moon J.C., McKenna W.J., McCrohon J.A., et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. JAm Coll Cardiol 2003, 41(9):1561-1567.
16. Shafee M.A., Fukuda K., Wakayama Y., et al. Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis. JCardiol 2012, 60(6):448-453.
17. Selvanayagam J.B., Leong D.P. MR imaging and cardiac amyloidosis: where to go from here?. JACC Cardiovasc Imaging 2010, 3(2):165-167.
18. Migrino R.Q., Christenson R., Szabo A., et al. Prognostic implication of late gadolinium enhancementin cardiac MRI on light chain (AL) amyloidosis on long term follow up. BMC Med Phys 2009, 9:5.
19. Marcus F.I., McKenna W.J., Sherrill D., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J 2010, 31(7):806-814.
20. Tandri H., Saranathan M., Rodriguez R.E., et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. JAm Coll Cardiol 2005, 45(1):98-103.